secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001493152-25-005456
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics issues shares under $15M SEPA; converts $2.9M note principal
---------------------------------------------------------------------------

- Issued 118,991 shares as commitment fee at $2.1010/share on Jan 7, 2025.
- Investor converted $900K, $500K, $500K, and $1.1M of Second Note between Jan 23 and Feb 7.
- Conversion prices ranged $1.4955 to $1.6301; total shares issued: 1,936,628.
- Second Note remaining principal is $2.0M as of Feb 7, 2025.
- Sale relied on Section 4(a)(2) exemption; no public offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000149315225005456/0001493152-25-005456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000149315225005456/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer